Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Jan 15;1812(4):480–487. doi: 10.1016/j.bbadis.2011.01.005

Figure 6.

Figure 6

Extracellular signal-regulated kinases 1/2 (ERK 1/2) phosphorylation in hippocampus of Alzheimer diseases (AD) and mild cognitive impairment (MCI) subjects. Brain samples of hippocampus (panels A and B) of subjects with AD or MCI were immunoprecipitated with anti-BVR-A antibody and assayed for phospho-ERK1/2 by Western Blot as described under Materials and Methods (sections 2.4 and 2.5). Densitometric values shown in the histograms are given as percentage of Control, set as 100%, and are the product of the band value of the levels of pERK 2 normalized per total BVR-A as loading control. In panels A-B representative gels are shown. Data are expressed as mean ± SD of six individual samples per group. *P<0.05 and **P < 0.01 versus Control (Student's t-test).

HHS Vulnerability Disclosure